您的位置: 首页 > 农业专利 > 详情页

The synthetic method of the pure CIS- imidazolinium compounds used for drug is generated for enantioselectivity
专利权人:
UNITY BIOTECHNOLOGY; INC.
发明人:
CHEN, BING,VON GELDERN, THOMAS W.,BACKES, BRADLEY
申请号:
CA3033850
公开号:
CA3033850A1
申请日:
2017.06.16
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The invention discloses a kind of methods of enantioselective synthesis for cis-imidazolines and in relation to structure by chiral resolution. A pair of of chiral acid is from a kind of racemic mixture by selective freezing for separating the enantiomer precursor of cis-imidazolines. Two enantiomers can be cyclized into required cis--imidazoline by complementary pathway. Compound can synthesize an enantiomeric excess high as 99% and can be used for treating cancer, kill senile cell, or processing aging-associated condition.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充